Nitric oxide 10 ppm and inhaled aerosolized prostacyclin 50 ng/kg/min were compared as selective pulmonary vasodilators in five patients with hypoxaemia secondary to acute respiratory distress syndrome. Neither agent resulted in systemic haemodynamic changes, indicating true pulmonary selectivity. Inhaled aerolized prostacyclin improved oxygenation to a degree comparable to nitric oxide, as measured by the arterial alveolar oxygen partial pressure gradient and shunt fraction.
KamPCA, GovenderG.Nitric oxide: basic science and clinical applications. Anaesthesia1994; 49:515–521.
4.
AnggardE.Nitric oxide: mediator, murderer, and medicine. Lancet1994; 343:1199–1206.
5.
GerlachH, RossaintR, PappertD, FalkeKJ.Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest1993; 23:499–502.
6.
YoungJD, BramptonWJ, KnightonJD, FinferSR.Inhaled nitric oxide in acute respiratory failure in adults. Br J Anaesth1994; 73:499–502.
7.
GerlachH, PappertD, LewandowskiK, RossaintR, FalkeKJ.Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intens Care Med1993: 19:443–449.
8.
ZapolWM.Minidose inhaled nitric oxide: less is better. Intens Care Med1993; 19:433–434.
9.
RadermacherP, SantakB, WustHJ, et al. Prostacyclin for the treatment of pulmonary hypertension in Adult Respiratory Distress Syndrome: Effects on pulmonary capillary pressure and ventilation—perfusion distributions. Anesthesiology1990; 72:238–244.
10.
BeinT, PfeiferM, RieggerGAJ, TaegerK.Continuous intra-arterial measurement of oxygenation during aerosolized prostacyclin administration in severe respiratory failure. (Letter). N Engl J Med1994; 331:335–336.
11.
WelteM, ZwisslerB, HabazettlH, MessmerK.PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res1993; 25:329–340.
12.
WalmrathD, SchneiderT, PilchJ, SchermulyR, GrimmingerF, SeegerW.Effects of aerosolized prostacyclin in severe pneumonia—Impact of fibrosis. Am J Respir Crit Care Med1995; 151:724–730.
ZwisslerB, WelteM, MessmerK.Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardio-thorac Vasc Anesth1995; 9:283–289.
15.
HaasNA, Schulze-NeickI, LangePE.Intratracheal prostacyclin for resuscitation in primary pulmonary hypertension. (Letter). Lancet1995; 346:643.
16.
BurghuberOC, SilberbauerK, HaberP, SinzingerH, ElliottM, LeithnerC.Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration1984; 45:450–454.
17.
WebbSAR, StottS, van HeerdenPV.The use of inhaled prostacyclin in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intens Care Med1996; 22(4):353–355.
18.
van HeerdenPV, WebbSAR, HeeG, CorkeronM, ThompsonWR.Inhaled aerosolised prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia. Anaesth Intens Care; 1996; 24(1):87–90.
19.
PappertD, BuschT, GerlachH, LewandowskiK, RadermacherP, RossaintR.Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology1995; 82(6):1507–1511.
20.
BernardGR, ArtigasA, BrighamKL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intens Care Med1994; 20:225–232.
21.
MurrayJF, MatthayMA, LuceJM, FlickMR.An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis1988; 138(3):720–723.
22.
O'RiordanTG, GrecoMJ, PerryRJ, SmaldoneGC.Nebulizer function during mechanical ventilation. Am Rev Respir Dis1992; 145:1117–1122.
23.
DurbinCD.Aerosol therapy in mechanically ventilated patients. Chest1994; 106(2):336–337.
